RxDoctor Payments Data

Mehran Khajavi, MD

Geriatric Medicine · Martinsburg, WVNPI 1013136464

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.4% of the total across 35 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 13 manufacturers, the largest accounting for just 20.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $558 and has fallen 94.3% since, to $32 in 2023.

$741in general payments, 2019–2025

Across 35 payments — averaging $21.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$154
  • AbbVie$154
  • Lilly USA, LLC$124
  • Boehringer Ingelheim$100
  • Abbott$90
  • AstraZeneca$25
  • plus $94 from 7 others

What the payments were for

  • Food & beverage$72998%
  • Education$122%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few geriatric medicine providers in West Virginiato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$8,650
Medicare patients
20
Services billed
115

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin19$11,375
ArexvyRsvpref3 Antigen/As01e/Pf39$5,733
ShingrixVaricella-Zoster Ge/As01b/Pf11$2,200
Atorvastatin Calcium100$1,122
Albuterol Sulfate HfaAlbuterol Sulfate29$888
Losartan Potassium44$446
Tamsulosin Hcl28$428
Amlodipine Besylate43$370
Levothyroxine Sodium23$352
Lisinopril39$336
Pantoprazole Sodium33$335
Tizanidine Hcl23$302
Metformin Hcl28$246
Rosuvastatin Calcium21$235
Fluticasone Propionate14$218

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$100$11,37519 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few geriatric medicine providers in West Virginiaon file to place this against a meaningful peer group, so we don't.

Other geriatric medicine in Martinsburg

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →